Invention Grant
US08410050B2 Method for achieving desired glial growth factor 2 plasma levels
有权
实现所需神经胶质细胞生长因子2血浆水平的方法
- Patent Title: Method for achieving desired glial growth factor 2 plasma levels
- Patent Title (中): 实现所需神经胶质细胞生长因子2血浆水平的方法
-
Application No.: US12380760Application Date: 2009-03-02
-
Publication No.: US08410050B2Publication Date: 2013-04-02
- Inventor: Haesun Kim , Anthony O. Caggiano
- Applicant: Haesun Kim , Anthony O. Caggiano
- Applicant Address: US NY Ardsley
- Assignee: Acorda Therapeutics, Inc.
- Current Assignee: Acorda Therapeutics, Inc.
- Current Assignee Address: US NY Ardsley
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent John A. Bauer; Katherine J. Miller
- Main IPC: A61K38/18
- IPC: A61K38/18
Abstract:
The present invention relates to administering glial growth factor 2 (GGF2) to a patient in need thereof, to achieve serum levels of GGF2 within a desired therapeutic window determined based on the disease or disorder afflicting the patient. In a particular embodiment, the patient is suffering from a disease or disorder associated with reduced levels of myelination and the GGF2 is administered to promote myelination in the patient.
Public/Granted literature
- US20100029559A1 Method for achieving desired glial growth factor 2 plasma levels Public/Granted day:2010-02-04
Information query
IPC分类:
